Advanced Medical Solutions Group plc (LON:AMS – Get Free Report)’s stock price reached a new 52-week high on Wednesday . The company traded as high as GBX 282 and last traded at GBX 280, with a volume of 1107860 shares. The stock had previously closed at GBX 280.
Analysts Set New Price Targets
Several research analysts have issued reports on the stock. Royal Bank Of Canada reiterated a “sector perform” rating and set a GBX 260 target price on shares of Advanced Medical Solutions Group in a report on Thursday, April 9th. Berenberg Bank reiterated a “buy” rating and set a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research note on Tuesday, May 19th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a GBX 275 price objective on shares of Advanced Medical Solutions Group in a research note on Friday, June 26th. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 270.25.
Get Our Latest Analysis on AMS
Advanced Medical Solutions Group Trading Up 0.1%
Advanced Medical Solutions Group Company Profile
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.
Featured Articles
- Five stocks we like better than Advanced Medical Solutions Group
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.
